Synthesis and evaluation of febrifugine analogues as potential antimalarial agents.
Febrifugine is an alkaloid isolated from Dichroa febrifuga Lour as the active component against Plasmodium falciparum. Strong liver toxicity has precluded febrifugine as a potential clinical drug. In this study novel febrifugine analogues were designed and synthesized. Lower toxicity was achieved by reducing or eliminating the tendency of forming chemically reactive and toxic intermediates and metabolites. Synthesized compounds were evaluated in vitro against chloroquine sensitive (D6) and chloroquine resistant (W2) P. falciparum strains for efficacy and in freshly isolated rat hepatocytes for potential cytotoxicity. The IC(50)'s of the best compounds were superior to their parent compound febrifugine. Noticeably, these compounds were also over 100 times less toxic than febrifugine. These compounds, as well as the underlying design rationale, may find usefulness in the discovery and development of new antimalarial drugs.
Zhu
Shuren
S
Radix Pharmaceuticals, Inc., 880 College Pkwy, Rockville, MD 20850, USA. shuren.zhu@gmail.com
Meng
Li
L
Zhang
Quan
Q
Wei
Lai
L
D000818:Animals; D000962:Antimalarials / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D022781:Hepatocytes / Q000469:parasitology; D009682:Magnetic Resonance Spectroscopy; D010880:Piperidines; D010963:Plasmodium falciparum / Q000187:drug effects; D011799:Quinazolines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats
D000962:Antimalarials; D010880:Piperidines; D011799:Quinazolines; C001207:febrifugine